GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » FCF Margin %

Virbac (Virbac) FCF Margin % : -0.96% (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Virbac FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Virbac's Free Cash Flow for the six months ended in Jun. 2023 was $-6 Mil. Virbac's Revenue for the six months ended in Jun. 2023 was $661 Mil. Therefore, Virbac's FCF Margin % for the quarter that ended in Jun. 2023 was -0.96%.

As of today, Virbac's current FCF Yield % is 2.69%.

The historical rank and industry rank for Virbac's FCF Margin % or its related term are showing as below:

VRBCF' s FCF Margin % Range Over the Past 10 Years
Min: 0.43   Med: 6.76   Max: 11.75
Current: 6.4


During the past 13 years, the highest FCF Margin % of Virbac was 11.75%. The lowest was 0.43%. And the median was 6.76%.

VRBCF's FCF Margin % is ranked better than
69.2% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs VRBCF: 6.40


Virbac FCF Margin % Historical Data

The historical data trend for Virbac's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac FCF Margin % Chart

Virbac Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.73 11.58 9.63 7.78 3.73

Virbac Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.36 13.14 -6.31 14.05 -0.96

Competitive Comparison of Virbac's FCF Margin %

For the Drug Manufacturers - General subindustry, Virbac's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Virbac's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Virbac's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Virbac's FCF Margin % falls into.



Virbac FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Virbac's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=48.101/1288.334
=3.73 %

Virbac's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-6.336/661.395
=-0.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Virbac FCF Margin % Related Terms

Thank you for viewing the detailed overview of Virbac's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Virbac (Virbac) Business Description

Traded in Other Exchanges
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.

Virbac (Virbac) Headlines

From GuruFocus

Full Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2020 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Virbac SA SFAF Meeting Transcript

By GuruFocus Research 03-08-2024

Full Year 2018 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2022 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2020 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2022 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024